Topiramate Tablet, Film Coated
Product Images NDC 68382-139

7 FDA label images from Zydus Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68382-139). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (59862b94 C1fb 465a 9a53 Ad5174f9d129 01)

Structured Product Formula For Topiramate (59862b94 C1fb 465a 9a53 Ad5174f9d129 01)
Chemical structure diagram of the active ingredient topiramate, showing its molecular connectivity and functional groups.*
FDA Label Image

Structured Product Formula For Topiramate (59862b94 C1fb 465a 9a53 Ad5174f9d129 02)

Structured Product Formula For Topiramate (59862b94 C1fb 465a 9a53 Ad5174f9d129 02)
A line graph showing cumulative rates for time to first seizure over time (days). It compares two dosage groups of topiramate: 50 mg/day (solid line) and 400 mg/day (dashed line). The graph includes sample sizes (N=234 and N=236 respectively) and shows that the 400 mg/day group has lower cumulative seizure rates over 500 days, with a p-value of 0.0002 indicating statistical significance.*
FDA Label Image

Topiramate Tablets Usp (59862b94 C1fb 465a 9a53 Ad5174f9d129 03)

Topiramate Tablets Usp (59862b94 C1fb 465a 9a53 Ad5174f9d129 03)
A bar graph showing change from baseline to double-blind phase in average monthly migraine period rate (+SE) for placebo and topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day. Data is presented for Study 11 and Study 12 with sample sizes indicated. Significance levels are marked with asterisks for the 100 mg/day and 200 mg/day groups.*
FDA Label Image

Topiramate Tablet-sl-25mg (59862b94 C1fb 465a 9a53 Ad5174f9d129 04)

Topiramate Tablet-sl-25mg (59862b94 C1fb 465a 9a53 Ad5174f9d129 04)
Topiramate Tablets USP 25 mg film-coated tablets label. The label includes the drug name, strength, and quantity of 60 tablets. It is labeled for Rx only use and manufactured by Zydus Pharmaceuticals (USA) Inc. The label contains storage instructions, child-resistant packaging notice, and pharmacist dispensing guideline.*
FDA Label Image

Topiramate Tablet-sl-25mg-60c (59862b94 C1fb 465a 9a53 Ad5174f9d129 05)

Topiramate Tablet-sl-25mg-60c (59862b94 C1fb 465a 9a53 Ad5174f9d129 05)
Topiramate Tablets, USP 50 mg film-coated tablets packaging label from Zydus Pharmaceuticals USA Inc., listing 60 tablets per container. Includes dosage strength, child-resistant packaging notice, storage instructions, and distributor information for Zydus Pharmaceuticals (USA) Inc.*
FDA Label Image

Topiramate Tablet-sl-100mg-60c (59862b94 C1fb 465a 9a53 Ad5174f9d129 06)

Topiramate Tablet-sl-100mg-60c (59862b94 C1fb 465a 9a53 Ad5174f9d129 06)
Topiramate Tablets, USP 100 mg film-coated oral tablets label from Zydus Pharmaceuticals USA Inc. The label indicates a package size of 60 tablets and prescription use only. It includes storage instructions, child-resistant packaging notice, and medication guide availability information. The NDC is 68382-140-14.*
FDA Label Image

200 mg (59862b94 C1fb 465a 9a53 Ad5174f9d129 07)

200 mg (59862b94 C1fb 465a 9a53 Ad5174f9d129 07)
Topiramate Tablets, USP 200 mg film-coated oral tablets labeled by Zydus Pharmaceuticals USA Inc. The package contains 60 tablets with a label advising the pharmacist to dispense the medication guide separately. Storage instructions and child-resistant packaging information are included, along with manufacturer and distributor details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.